Sponsored Research
Pamela S. Douglas of Cardiology has received a sub-award (5U10-CA081920-12) through the University of South Florida for a project entitled "SCUSF 0806 Phase II placebo--controlled trial of lisinopril and Coreg." Total funding will be $50,000.
Adrian F. Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "PCORI Short Term Communications Procurement Plan." Total funding will be $116,444.
Eric D. Peterson of Cardiology has received an award from the Food and Drug Administration for a project entitled "IPA with the FDA." Total funding will be $197,249.
Geoffrey Pitt of Cardiology has received an award (2T32-HL007101-41) from the National Institutes of Health for a project entitled "Multidisciplinary Heart and Vascular Diseases." Total funding will be $2,886,333.
Matthew T. Roe of Cardiology has received an award from the American College of Cardiology Foundation for a project entitled "ACC-NCDR Partnership with Institutional Research Center." Total funding will be $290,124.
Mark N. Feinglos of Endocrinology, Metabolism, and Nutrition has received a sub-award (HHSN268201100027C) through the Wake Forest University School of Medicine for a project entitled "Prevention of cardiovascular disease in diabetes mellitus-clinical center network sites." Total funding will be $7,130.
Diego Bohorquez of Gastroenterology has received an award from the Hartwell Foundation for a project entitled "Targeting a gut sensory neural circuit in autism spectrum disorders." Total funding will be $300,000.
Connie Bales of Geriatrics has received an award from the National Cattlemen's Beef Association for a project entitled "Does Beef Protein Preserve Muscle Mass and Function During Weight Loss in Frail, Obese Older Adults? A Follow-Up Study." Total funding will be $47,777.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from the Fred Hutchinson Cancer Research Center for a project entitled "Improving Outcomes of Older and Medically Infirm Patients with AML." Total funding will be $9,280.
Andrew Alspaugh of Infectious Diseases has received an award (2R01-AI074677-06) from the National Institutes of Health for a project entitled "Coordinated Regulation of Virulence Genes in C. neoformans." Total funding will be $2,087,612.
John A. Bartlett of Infectious Diseases has received an award (1R56-HL126537-01) from the National Institutes of Health for a project entitled "HIV and Asthma in the Post- ART Era." Total funding will be $729,181.
Mehri McKellar of Infectious Diseases has received a sub-award (U62-PS0003658-) through the NC DHHS for a project entitled "Healthy Relationships: Region Seven Prevention for Positives." Total funding will be $60,000.
Mehri McKellar of Infectious Diseases has received a sub-award (X07HA00051) through the NC Dept of Health and Human Services for a project entitled "Ryan White Part B Region 7 Network of Care." Total funding will be $450,389.
Herbert I. Hurwitz of Medical Oncology has received an award (3UM1-CA186704-03S1) from the National Institutes of Health for a project entitled "Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer." Total funding will be $884,114.
Arif H. Kamal of Medical Oncology has received an award from the American Society of Clinical Oncology for a project entitled "Improving the Delivery of Cancer Care in Medically Underserved Communities." Total funding will be $119,650.
Steven D. Crowley of Nephrology has received an award (2R01-DK087893-06A1) from the National Institutes of Health for a project entitled "Role of Th1 Immune Responses in the Pathogenesis of Hypertensive Kidney Injury." Total funding will be $715,500.
Kim M. Huffman of Rheumatology and Immunology has received a sub-award (CER-1306-02043) through the University of North Carolina - Chapel Hill for a project entitled "Physical Therapy vs. Internet-Based Exercise Training for Patients with Knee Osteoarthritis." Total funding will be $36,852.
Industry-sponsored Clinical Trials
Robert W. Harrison of Cardiology has received an award from Janssen Scientific Affairs, LLC for a project entitled "OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban & a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects w/ Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention." Total funding will be $662,968.
Adrian F. Hernandez of Cardiology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "DCRI Learning Lab: Heart Failure." Total funding will be $100,881.
Adrian F. Hernandez of Cardiology has received an award from Aires Pharmaceuticals, Inc. for a project entitled "HFN - INDIE - Aires Pharmaceuticals." Total funding will be $2,950,000.
Renato D. Lopes of Cardiology has received an award from Merck for a project entitled "Vericiguat VICTORIA." Total funding will be $375,698.
Emily O'Brien of Cardiology has received an award from Novartis Vaccines and Diagnostics, Inc for a project entitled "Early Adoption of Novel Heart Failure Therapy and Patient-Prioritized Outcomes in Clinical Practice." Total funding will be $658,242.
Pierluigi Tricoci of Cardiology has received an award from the CSL Limited for a project entitled "CSL Phase IIa Extension." Total funding will be $3,955,064.
David D'Alessio of Endocrinology, Metabolism, and Nutrition has received an award from Merck Sharp & Dohme for a project entitled "Role of Islet GLP-1 and DPP-4 in Insulin Secretion." Total funding will be $184,219.
Cristina Gasparetto of Hematological Malignancies and Cellular Therapy has received an award from Merck Sharp & Dohme for a project entitled "Phase III study of Pomalidomide and low dose Dex with or without Pembrolizumab (MK3475) in MM." Total funding will be $180,699.
Murat O. Arcasoy of Hematology has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 2, Open-label, Translational Biology Study of Momelotinib in Transfusion-Dependent Subjects." Total funding will be $106,150.
Nirmish R. Shah of Hematology has received an award from Mast Therapeutics, Inc. for a project entitled "Mst-188-04 Evaluation Of Repeat Administration Of Purified Poloxamer 188 In Vaso-Occlusive Crisis Of Sickle Cell Disease (Epic-E): An Open-Label Safety Extension Trial Assessing Repeat Administration Of Mst-188 (Purified Poloxamer 188) Injection." Total funding will be $180,465.
Vance G. Fowler of Infectious Diseases has received an award from ContraFect Corporation for a project entitled "Cross-reactive Antibodies to CF-301 Associated with Staphylococcus aureus Bacteremia in a Tertiary Medical Center in the Southeastern United States." Total funding will be $92,450.
Mehri McKellar of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled "GS-US-380-1961." Total funding will be $53,639.
Susanna Naggie of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled "GS-US-366-1992." Total funding will be $95,039.
John Perfect of Infectious Diseases has received an award from T2 Biosystems, Inc for a project entitled "T2 Bacteria Panel Pivotal Study." Total funding will be $82,170.
Andrew Armstrong of Medical Oncology has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 1b/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination with Enzalutamide in Subjects with Metastatic Castrate-Resistant Prostate Cancer." Total funding will be $349,002.
Kimberly L. Blackwell of Medical Oncology has received an award from Genentech, Inc. for a project entitled "Phase I Dose Escalation Trial of Intrathecal Pertuzumab and Trastuzumab in Patients with New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer." Total funding will be $6,048.
Jeffrey Crawford of Medical Oncology has received an award from Morphotek, Inc for a project entitled "A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Pleural Mesothelioma." Total funding will be $5,876.
Richard F. Riedel of Medical Oncology has received an award from Tokalas, Inc. for a project entitled "Ewings Sarcoma Phase I study LOI." Total funding will be $2,657,261.
Patrick H. Pun of Nephrology has received an award from DaVita Clinical Research for a project entitled "Wearable Cardioverter Defibrillator (Zoll Study)." Total funding will be $73,479.
Njira L. Lugogo of Pulmonary, Allergy, and Critical Care Medicine has received an award from GlaxoSmithKline for a project entitled "A multi-center, randomized, double-blind, placebo controlled, parallel group study to compare cessation versus continuation of long-term mepolizumab treatment in patients with severe eosinophilic asthma (201810)." Total funding will be $345,003.
Kamran Mahmood of Pulmonary, Allergy, and Critical Care Medicine has received an award from the Olympus Corporation for a project entitled "Current Trends in Pleural Disease Management." Total funding will be $5,000.
Virginia B. Kraus of Rheumatology and Immunology has received an award from Bioiberica, S.A. for a project entitled "Proteomics Ancillary Study of the MOVES Trial." Total funding will be $56,343.